Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,268,952
  • Shares Outstanding, K 255,756
  • Annual Sales, $ 7,574 M
  • Annual Income, $ 2,342 M
  • 60-Month Beta 0.55
  • Price/Sales 9.07
  • Price/Cash Flow 21.25
  • Price/Book 6.30
Trade VRTX with:

Options Overview Details

View History
  • Implied Volatility 33.10% ( -0.14%)
  • Historical Volatility 42.52%
  • IV Percentile 44%
  • IV Rank 34.70%
  • IV High 54.54% on 02/01/22
  • IV Low 21.70% on 09/07/21
  • Put/Call Vol Ratio 1.03
  • Today's Volume 481
  • Volume Avg (30-Day) 1,137
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 44,508
  • Open Int (30-Day) 46,462

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 3.16
  • Number of Estimates 9
  • High Estimate 3.29
  • Low Estimate 3.05
  • Prior Year 2.80
  • Growth Rate Est. (year over year) +12.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
233.01 +15.72%
on 05/11/22
279.71 -3.60%
on 04/29/22
+1.96 (+0.73%)
since 04/26/22
3-Month
226.18 +19.22%
on 02/28/22
292.75 -7.89%
on 04/14/22
+39.35 (+17.09%)
since 02/25/22
52-Week
176.36 +52.90%
on 10/06/21
292.75 -7.89%
on 04/14/22
+62.85 (+30.39%)
since 05/26/21

Most Recent Stories

More News
EQUITY ALERT: Rosen Law Firm Encourages Vertex Pharmaceuticals Incorporated Investors with Losses to Inquire About Class Action Investigation – VRTX

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) resulting...

VRTX : 269.65 (-0.44%)
3 Healthcare Stocks You Can Buy and Hold for the Next Decade

They're leaders in their fields.

VRTX : 269.65 (-0.44%)
ISRG : 223.30 (+0.32%)
ABBV : 150.57 (-0.91%)
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

PBE : 56.75 (+0.69%)
AMGN : 253.05 (+0.02%)
VRTX : 269.65 (-0.44%)
IBB : 115.80 (+0.90%)
TECH : 365.32 (+3.55%)
XBI : 68.47 (+1.09%)
S&P Futures Show Speculation on End-Of-Day Gains

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 4,057.84 (+1.99%)
SPY : 405.31 (+2.00%)
$DOWI : 32,637.19 (+1.61%)
DIA : 326.45 (+1.61%)
$IUXX : 12,276.79 (+2.79%)
QQQ : 299.33 (+2.77%)
PANW : 502.09 (-0.68%)
C : 54.09 (+2.64%)
BAC : 36.67 (+2.32%)
CMA : 81.64 (+3.13%)
WFC : 45.60 (+3.35%)
COF : 124.41 (+3.49%)
Catalyst Biosciences Sells Complement Portfolio for $60 Million

SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that it has signed a definitive...

CBIO : 1.1100 (-22.38%)
VRTX : 269.65 (-0.44%)
2 Recession Stocks to Buy Right Now

Multi-decade-high inflation and aggressive Fed rate increases might push the economy into a recession. So, investors looking to mitigate a market downturn should invest in Dollar Tree (DLTR) and Vertex...

DLTR : 162.80 (+21.87%)
VRTX : 269.65 (-0.44%)
Have $2,000? 2 Market Crash-Ready Stocks to Buy

These stocks have great long-term prospects.

VRTX : 269.65 (-0.44%)
CRSP : 55.23 (+1.25%)
PFE : 53.99 (+0.52%)
BHVN : 143.18 (-0.15%)
The Zacks Analyst Blog Highlights Alibaba, McDonald, Advanced Micro Devices, Abbott Laboratories, and Vertex Pharmaceuticals

Alibaba, McDonald, Advanced Micro Devices, Abbott Laboratories, and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.

ABT : 114.87 (+1.48%)
AMD : 98.75 (+6.58%)
MCD : 248.09 (+1.67%)
VRTX : 269.65 (-0.44%)
BABA : 94.48 (+14.79%)
3 of the Smartest Stocks to Buy in a Fed-Induced Bear Market

A plunging stock market is the ideal time to put your money to work in these time-tested companies.

COMP : 5.36 (+1.13%)
NEE : 75.04 (+0.33%)
ARLP : 19.88 (-0.10%)
VRTX : 269.65 (-0.44%)
Top Stock Reports for Alibaba, McDonald's & Advanced Micro Devices

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), McDonald's Corporation (MCD), and Advanced Micro Devices, Inc. (AMD).

ABT : 114.87 (+1.48%)
AMD : 98.75 (+6.58%)
MDT : 99.44 (-5.78%)
MCD : 248.09 (+1.67%)
VRTX : 269.65 (-0.44%)
BABA : 94.48 (+14.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 278.22
2nd Resistance Point 276.19
1st Resistance Point 272.92
Last Price 269.65
1st Support Level 267.63
2nd Support Level 265.60
3rd Support Level 262.33

See More

52-Week High 292.75
Last Price 269.65
Fibonacci 61.8% 248.29
Fibonacci 50% 234.55
Fibonacci 38.2% 220.82
52-Week Low 176.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar